多发性-话题@MedSci

#多发性#

905篇内容 | 2918人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890400, encodeId=db591890400a7, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:在接受芬戈莫德治疗的多发性硬化症患者中，SARS-CoV-2 mRNA疫苗接种未能引发体液和细胞免疫反应, objectType=article, longId=734385, objectId=84d8e34385a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84d8e34385a7, replyNumber=0, likeNumber=132, createdTime=2023-05-17, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84d8e34385a7, moduleTitle=JNNP:在接受芬戈莫德治疗的多发性硬化症患者中，SARS-CoV-2 mRNA疫苗接种未能引发体液和细胞免疫反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84d8e34385a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890414, encodeId=57661890414cf, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Investigative Radiology：这一MR技术，为多发性硬化的颈髓病变显示“加装备”！, objectType=article, longId=737670, objectId=9d92e376706f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d92e376706f, replyNumber=0, likeNumber=153, createdTime=2023-05-17, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d92e376706f, moduleTitle=Investigative Radiology：这一MR技术，为多发性硬化的颈髓病变显示“加装备”！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d92e376706f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890404, encodeId=bee41890404d6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=J Clin Oncol：埃罗妥珠单抗联合泊马度胺和地塞米松可显著改善复发/难治性多发性骨髓瘤生存预后, objectType=article, longId=736048, objectId=4468e3604828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4468e3604828, replyNumber=0, likeNumber=134, createdTime=2023-06-20, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4468e3604828, moduleTitle=J Clin Oncol：埃罗妥珠单抗联合泊马度胺和地塞米松可显著改善复发/难治性多发性骨髓瘤生存预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4468e3604828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890412, encodeId=78ff189041215, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Radiology：这些MRI指标在预测多发性骨髓瘤患者早期治疗反应中的应用, objectType=article, longId=737556, objectId=75c7e37556ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75c7e37556ec, replyNumber=0, likeNumber=103, createdTime=2022-12-26, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75c7e37556ec, moduleTitle=Radiology：这些MRI指标在预测多发性骨髓瘤患者早期治疗反应中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75c7e37556ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890397, encodeId=f91f189039e8f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=排除多发性肌炎的关键指标, objectType=article, longId=734239, objectId=259ae3423999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=259ae3423999, replyNumber=0, likeNumber=98, createdTime=2022-08-04, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=259ae3423999, moduleTitle=排除多发性肌炎的关键指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=259ae3423999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890390, encodeId=2dd31890390e6, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=【精简版】2022年中国多发性骨髓瘤诊治指南更新要点，一目了然, objectType=article, longId=732132, objectId=3762e32132ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3762e32132ae, replyNumber=0, likeNumber=102, createdTime=2022-09-21, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3762e32132ae, moduleTitle=【精简版】2022年中国多发性骨髓瘤诊治指南更新要点，一目了然, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3762e32132ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890394, encodeId=20b31890394aa, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=塞利尼索在中国成功上市，开启多发性骨髓瘤治疗新篇章, objectType=article, longId=732614, objectId=29d3e32614db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29d3e32614db, replyNumber=0, likeNumber=111, createdTime=2023-02-17, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29d3e32614db, moduleTitle=塞利尼索在中国成功上市，开启多发性骨髓瘤治疗新篇章, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29d3e32614db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890405, encodeId=9a46189040589, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP：利妥昔单抗治疗多发性硬化症期间母乳喂养的安全性, objectType=article, longId=736162, objectId=46eae3616226, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46eae3616226, replyNumber=0, likeNumber=148, createdTime=2023-06-27, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46eae3616226, moduleTitle=JNNP：利妥昔单抗治疗多发性硬化症期间母乳喂养的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46eae3616226)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890409, encodeId=fc8018904097e, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=European Radiology：DTI在视神经脊髓炎谱系疾病和多发性硬化症鉴别中的价值, objectType=article, longId=736905, objectId=4144e369053a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4144e369053a, replyNumber=0, likeNumber=122, createdTime=2023-07-31, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4144e369053a, moduleTitle=European Radiology：DTI在视神经脊髓炎谱系疾病和多发性硬化症鉴别中的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4144e369053a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890379, encodeId=321f18903e9b1, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:多发性硬化发病时，患者的年龄在往后推移, objectType=article, longId=727792, objectId=2fb7e277929c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fb7e277929c, replyNumber=0, likeNumber=137, createdTime=2022-07-21, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fb7e277929c, moduleTitle=JNNP:多发性硬化发病时，患者的年龄在往后推移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fb7e277929c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890388, encodeId=64851890388b0, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=小肠多发性狭窄，是克罗恩病吗？, objectType=article, longId=731458, objectId=0e52e3145849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e52e3145849, replyNumber=0, likeNumber=115, createdTime=2023-03-18, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e52e3145849, moduleTitle=小肠多发性狭窄，是克罗恩病吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e52e3145849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890375, encodeId=ca0d18903e529, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Cancer Med：肺动脉高压是新诊断多发性骨髓瘤患者的不良预后因素, objectType=article, longId=726304, objectId=ca59e2630405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca59e2630405, replyNumber=0, likeNumber=118, createdTime=2022-06-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca59e2630405, moduleTitle=Cancer Med：肺动脉高压是新诊断多发性骨髓瘤患者的不良预后因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca59e2630405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890391, encodeId=39ea189039199, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=INVEST RADIO:一种使用MRI预测多发性硬化症疾病进展的深度学习方法, objectType=article, longId=732322, objectId=60d1e3232267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60d1e3232267, replyNumber=0, likeNumber=130, createdTime=2023-05-18, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60d1e3232267, moduleTitle=INVEST RADIO:一种使用MRI预测多发性硬化症疾病进展的深度学习方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60d1e3232267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890398, encodeId=aece18903982c, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JAMA Oncol：Elotuzumab联合每周KRd治疗新诊断的多发性骨髓瘤, objectType=article, longId=734229, objectId=6890e34229fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6890e34229fe, replyNumber=0, likeNumber=109, createdTime=2023-01-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6890e34229fe, moduleTitle=JAMA Oncol：Elotuzumab联合每周KRd治疗新诊断的多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6890e34229fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890368, encodeId=3b68189036803, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=BJH：达雷妥尤单抗治疗多发性骨髓瘤的结果：来自加拿大骨髓瘤研究组数据库的回顾性队列研究, objectType=article, longId=723821, objectId=b5abe23821ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5abe23821ca, replyNumber=0, likeNumber=107, createdTime=2023-03-08, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5abe23821ca, moduleTitle=BJH：达雷妥尤单抗治疗多发性骨髓瘤的结果：来自加拿大骨髓瘤研究组数据库的回顾性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5abe23821ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890386, encodeId=7dcb1890386d9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多发性硬化症与脑小血管病的鉴别诊断, objectType=article, longId=730315, objectId=fb1de30315e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb1de30315e8, replyNumber=0, likeNumber=102, createdTime=2022-09-26, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb1de30315e8, moduleTitle=多发性硬化症与脑小血管病的鉴别诊断, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb1de30315e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890374, encodeId=ffde18903e488, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle= BJH：达雷妥尤单抗、来那度胺和地塞米松在新诊断的与多发性骨髓瘤相关的全身性轻链淀粉样变性患者中的应用, objectType=article, longId=726507, objectId=868be26507ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=868be26507ef, replyNumber=0, likeNumber=120, createdTime=2023-01-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=868be26507ef, moduleTitle= BJH：达雷妥尤单抗、来那度胺和地塞米松在新诊断的与多发性骨髓瘤相关的全身性轻链淀粉样变性患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=868be26507ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890369, encodeId=f54e189036910, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:儿童期不良经历与多发性硬化症的关系, objectType=article, longId=723792, objectId=5098e2379207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5098e2379207, replyNumber=0, likeNumber=110, createdTime=2023-03-10, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5098e2379207, moduleTitle=JNNP:儿童期不良经历与多发性硬化症的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5098e2379207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890395, encodeId=7772189039556, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=武田发布评估HYQVIA®用于慢性炎性脱髓鞘性多发性神经根神经病(CIDP)维持治疗的枢纽性3期临床试验阳性顶线结果, objectType=article, longId=733249, objectId=a155e3324911, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a155e3324911, replyNumber=0, likeNumber=0, createdTime=2022-12-23, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a155e3324911, moduleTitle=武田发布评估HYQVIA®用于慢性炎性脱髓鞘性多发性神经根神经病(CIDP)维持治疗的枢纽性3期临床试验阳性顶线结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a155e3324911)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890407, encodeId=d7c6189040e7f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=European Radiology：进行性多发性硬化患者的脑血流量对全身动脉循环的依赖性, objectType=article, longId=736811, objectId=b109e36811f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b109e36811f7, replyNumber=0, likeNumber=118, createdTime=2023-06-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b109e36811f7, moduleTitle=European Radiology：进行性多发性硬化患者的脑血流量对全身动脉循环的依赖性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b109e36811f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:在接受芬戈莫德治疗的多发性硬化症患者中，SARS-CoV-2 mRNA疫苗接种未能引发体液和细胞免疫反应

2023-05-17

heli0118 (审核中...)

前往app查看评论内容

#多发性#

Investigative Radiology：这一MR技术，为多发性硬化的颈髓病变显示“加装备”！

2023-05-17

jml2009 (审核中...)

前往app查看评论内容

#多发性#

J Clin Oncol：埃罗妥珠单抗联合泊马度胺和地塞米松可显著改善复发/难治性多发性骨髓瘤生存预后

2023-06-20

heli0118 (审核中...)

前往app查看评论内容

#多发性#

Radiology：这些MRI指标在预测多发性骨髓瘤患者早期治疗反应中的应用

2022-12-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

排除多发性肌炎的关键指标

2022-08-04

jml2009 (审核中...)

前往app查看评论内容

#多发性#

【精简版】2022年中国多发性骨髓瘤诊治指南更新要点，一目了然

2022-09-21

jml2009 (审核中...)

前往app查看评论内容

#多发性#

塞利尼索在中国成功上市，开启多发性骨髓瘤治疗新篇章

2023-02-17

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP：利妥昔单抗治疗多发性硬化症期间母乳喂养的安全性

2023-06-27

jml2009 (审核中...)

前往app查看评论内容

#多发性#

European Radiology：DTI在视神经脊髓炎谱系疾病和多发性硬化症鉴别中的价值

2023-07-31

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:多发性硬化发病时，患者的年龄在往后推移

2022-07-21

jml2009 (审核中...)

前往app查看评论内容

#多发性#

小肠多发性狭窄，是克罗恩病吗？

2023-03-18

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Cancer Med：肺动脉高压是新诊断多发性骨髓瘤患者的不良预后因素

2022-06-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

INVEST RADIO:一种使用MRI预测多发性硬化症疾病进展的深度学习方法

2023-05-18

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JAMA Oncol：Elotuzumab联合每周KRd治疗新诊断的多发性骨髓瘤

2023-01-12

jml2009 (审核中...)

前往app查看评论内容

#多发性#

BJH：达雷妥尤单抗治疗多发性骨髓瘤的结果：来自加拿大骨髓瘤研究组数据库的回顾性队列研究

2023-03-08

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多发性硬化症与脑小血管病的鉴别诊断

2022-09-26

jml2009 (审核中...)

前往app查看评论内容

#多发性#

BJH：达雷妥尤单抗、来那度胺和地塞米松在新诊断的与多发性骨髓瘤相关的全身性轻链淀粉样变性患者中的应用

2023-01-12

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:儿童期不良经历与多发性硬化症的关系

2023-03-10

jml2009 (审核中...)

前往app查看评论内容

#多发性#

武田发布评估HYQVIA®用于慢性炎性脱髓鞘性多发性神经根神经病(CIDP)维持治疗的枢纽性3期临床试验阳性顶线结果

2022-12-23

jml2009 (审核中...)

前往app查看评论内容

#多发性#

European Radiology：进行性多发性硬化患者的脑血流量对全身动脉循环的依赖性

2023-06-12

科室
- - 订阅+
  - 更多科室
工具
服务